ID: ALA3561654

Max Phase: Preclinical

Molecular Formula: C29H28F4N4O5

Molecular Weight: 474.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NCCN1CCC2(CC1)C(=O)NCN2C(=O)c1cccc(F)c1)c1ccc2ccccc2c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C27H27FN4O3.C2HF3O2/c28-23-7-3-6-22(17-23)25(34)32-18-30-26(35)27(32)10-13-31(14-11-27)15-12-29-24(33)21-9-8-19-4-1-2-5-20(19)16-21;3-2(4,5)1(6)7/h1-9,16-17H,10-15,18H2,(H,29,33)(H,30,35);(H,6,7)

Standard InChI Key:  XYLLRLIJACFXKM-UHFFFAOYSA-N

Associated Targets(Human)

Phospholipase D2 437 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Phospholipase D1 469 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 474.54Molecular Weight (Monoisotopic): 474.2067AlogP: 2.77#Rotatable Bonds: 5
Polar Surface Area: 81.75Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.07CX Basic pKa: 7.49CX LogP: 2.37CX LogD: 2.02
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.60Np Likeness Score: -1.25

References

1. PubChem BioAssay data set, 

Source

Source(1):